Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
暂无分享,去创建一个
Alan McClelland | Katherine A. High | Mark A. Kay | Bertil Glader | Alan W. Flake | M. Kay | R. Herzog | K. High | C. Manno | M. Ragni | P. Larson | L. Couto | A. Mcclelland | B. Glader | A. Chew | S. J. Tai | V. Arruda | F. Johnson | C. Scallan | E. Skarsgard | A. Flake | Catherine S. Manno | Margaret V. Ragni | Peter J. Larson | Linda B. Couto | Amy J. Chew | Shing J Tai | Roland W. Herzog | Valder Arruda | Fred Johnson | Ciaran Scallan | Erik Skarsgard
[1] K. Kurachi,et al. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). , 1985, Biochemistry.
[2] K. Kurachi,et al. Role of Intron I in Expression of the Human Factor IX Gene (*) , 1995, The Journal of Biological Chemistry.
[3] D. A. Quarles,et al. Progress and problems , 1953, Electrical Engineering.
[4] J. van den Born,et al. Identification of the endothelial cell binding site for factor IX. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Samulski,et al. Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.
[6] S. Malcolm,et al. Guidelines for Research Involving Recombinant DNA Molecules , 1978, Federal register.
[7] Katherine A. High,et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector , 1999, Nature Medicine.
[8] Keyun Qing,et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 , 1999, Nature Medicine.
[9] W. Parks,et al. Seroepidemiological and Ecological Studies of the Adenovirus-Associated Satellite Viruses , 1970, Infection and immunity.
[10] James M. Wilson,et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Mitchell,et al. Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] Jeffrey H. Miller. Experiments in molecular genetics , 1972 .
[13] M. Sands,et al. Successful expression of human factor IX following repeat administration of adenoviral vector in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] H. Pettersson,et al. Haemophilia prophylaxis in young patients–a long‐term follow‐up , 1997, Journal of internal medicine.
[15] P. Mannucci,et al. The hemophilias: progress and problems. , 1999, Seminars in hematology.
[16] Caleb S. Stone,et al. Progress and Problems , 1961 .
[17] R. Ljung. Can haemophilic arthropathy be prevented? , 1998, British journal of haematology.
[18] L. Villarreal,et al. Adeno-associated virus vectors can be efficiently produced without helper virus , 1998, Gene Therapy.